Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...

Closing of the Purchase Agreement will be subject to several closing conditions, including: (i) approval by the shareholders of Steep Hill; receipt of all necessary regulatory approvals, including of ...

The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Emily Fontaine, Global Head of Venture Capital, IBM; Jay Love, US Chief Investment Strategist, Mercer; and Alan McKnight, Chief Investment Officer, Regions Bank join Bloomberg Intelligence's ...